These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30003951)

  • 1. Poly-ubiquitin profile in Alzheimer disease brain.
    Tramutola A; Triani F; Di Domenico F; Barone E; Cai J; Klein JB; Perluigi M; Butterfield DA
    Neurobiol Dis; 2018 Oct; 118():129-141. PubMed ID: 30003951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyubiquitinylation Profile in Down Syndrome Brain Before and After the Development of Alzheimer Neuropathology.
    Tramutola A; Di Domenico F; Barone E; Arena A; Giorgi A; di Francesco L; Schininà ME; Coccia R; Head E; Butterfield DA; Perluigi M
    Antioxid Redox Signal; 2017 Mar; 26(7):280-298. PubMed ID: 27627691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Levels of Extracellular Microvesicle Markers and Decreased Levels of Endocytic/Exocytic Proteins in the Alzheimer's Disease Brain.
    Musunuri S; Khoonsari PE; Mikus M; Wetterhall M; Häggmark-Mänberg A; Lannfelt L; Erlandsson A; Bergquist J; Ingelsson M; Shevchenko G; Nilsson P; Kultima K
    J Alzheimers Dis; 2016 Oct; 54(4):1671-1686. PubMed ID: 27636840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD.
    Owen JB; Di Domenico F; Sultana R; Perluigi M; Cini C; Pierce WM; Butterfield DA
    J Proteome Res; 2009 Feb; 8(2):471-82. PubMed ID: 19072283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease--an interactive perspective.
    Heese K; Akatsu H
    Curr Alzheimer Res; 2006 Apr; 3(2):109-21. PubMed ID: 16611011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological and immunohistochemical comparison of the brain of human patients with Alzheimer's disease and the brain of aged dogs with cognitive dysfunction.
    Yu CH; Song GS; Yhee JY; Kim JH; Im KS; Nho WG; Lee JH; Sur JH
    J Comp Pathol; 2011 Jul; 145(1):45-58. PubMed ID: 21256508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-amyloid racemized at the Ser26 residue in the brains of patients with Alzheimer disease: implications in the pathogenesis of Alzheimer disease.
    Kubo T; Kumagae Y; Miller CA; Kaneko I
    J Neuropathol Exp Neurol; 2003 Mar; 62(3):248-59. PubMed ID: 12638729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic identification of nitrated brain proteins in early Alzheimer's disease inferior parietal lobule.
    Reed TT; Pierce WM; Turner DM; Markesbery WR; Allan Butterfield D
    J Cell Mol Med; 2009 Aug; 13(8B):2019-2029. PubMed ID: 18752637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of tau phosphorylation in Alzheimer's disease.
    Lee VM
    Ann N Y Acad Sci; 1996 Jan; 777():107-13. PubMed ID: 8624072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain site-specific gene expression analysis in Alzheimer's disease patients.
    Yokota T; Mishra M; Akatsu H; Tani Y; Miyauchi T; Yamamoto T; Kosaka K; Nagai Y; Sawada T; Heese K
    Eur J Clin Invest; 2006 Nov; 36(11):820-30. PubMed ID: 17032350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's Disease.
    Abreha MH; Dammer EB; Ping L; Zhang T; Duong DM; Gearing M; Lah JJ; Levey AI; Seyfried NT
    Proteomics; 2018 Oct; 18(20):e1800108. PubMed ID: 30230243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
    Tomiyama T
    Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Explorative and targeted neuroproteomics in Alzheimer's disease.
    Brinkmalm A; Portelius E; Öhrfelt A; Brinkmalm G; Andreasson U; Gobom J; Blennow K; Zetterberg H
    Biochim Biophys Acta; 2015 Jul; 1854(7):769-78. PubMed ID: 25619854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunolocalization of Tom1 in relation to protein degradation systems in Alzheimer's disease.
    Makioka K; Yamazaki T; Takatama M; Ikeda M; Murayama S; Okamoto K; Ikeda Y
    J Neurol Sci; 2016 Jun; 365():101-7. PubMed ID: 27206884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology.
    Kadokura A; Yamazaki T; Lemere CA; Takatama M; Okamoto K
    Neuropathology; 2009 Oct; 29(5):566-73. PubMed ID: 19422539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics.
    Aluise CD; Robinson RA; Beckett TL; Murphy MP; Cai J; Pierce WM; Markesbery WR; Butterfield DA
    Neurobiol Dis; 2010 Aug; 39(2):221-8. PubMed ID: 20399861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.